Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.77 USD | +1.97% | +2.64% | -7.94% |
04-02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
04-02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Business Summary
Number of employees: 162
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Therapies
100.0
%
| 41 | 100.0 % | 250 | 100.0 % | +511.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 250 | 100.0 % | +511.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 28/02/22 |
Michael Higgins
CHM | Chairman | 61 | 21/07/15 |
Director of Finance/CFO | 55 | 18/09/22 | |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 54 | 31/10/18 |
Robin Swartz
COO | Chief Operating Officer | 53 | 31/08/21 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 04/01/17 |
James Geraghty
BRD | Director/Board Member | 70 | 31/12/13 |
Beth Shafer
PRN | Corporate Officer/Principal | - | 06/08/23 |
Human Resources Officer | - | 13/09/20 | |
General Counsel | - | 09/07/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 08/05/23 |
James Geraghty
BRD | Director/Board Member | 70 | 31/12/13 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 04/01/17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 14/08/22 |
Steven E. Hyman
BRD | Director/Board Member | 71 | 16/09/15 |
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 28/02/22 |
Grace E. Colón
BRD | Director/Board Member | 57 | 31/12/22 |
Nancy J. Vitale
BRD | Director/Board Member | - | 14/09/20 |
Michael Higgins
CHM | Chairman | 61 | 21/07/15 |
Jude Onyia
BRD | Director/Board Member | 60 | 20/02/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,388,336 | 45,192,190 ( 83.09 %) | 0 | 83.09 % |
Company contact information
Voyager Therapeutics, Inc.
75 Hayden Avenue
02421, Lexington
+857 259 5340
http://www.voyagertherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.94% | 423M | |
+1.77% | 42.86B | |
+46.73% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- VYGR Stock
- Company Voyager Therapeutics, Inc.